Advertisement

Topics

Astellas Hunts for Prospects with $3.6B Cash to Spend

16:39 EST 1 Dec 2016 | Pharmaceutical Manfacturing

Astellas is now a close competitor with rival Takeda Pharmaceutical Co. to become Japan’s biggest drugmaker by value

Original Article: Astellas Hunts for Prospects with $3.6B Cash to Spend

NEXT ARTICLE

More From BioPortfolio on "Astellas Hunts for Prospects with $3.6B Cash to Spend"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...